• FirefoxInstall the new Firefox »
  •  Dow Down 0.06% Nasdaq Up 0.42%

    Isis Pharmaceuticals, Inc. (ISIS)

    -NasdaqGS
    67.33 Down 0.82(1.20%) 4:00PM EST
    |After Hours : 67.96 Up 0.63 (0.94%) 7:59PM EST
    Add to Portfolio
    Prev Close:68.15
    Open:67.96
    Bid:67.76 x 100
    Ask:N/A
    1y Target Est:65.22
    Beta:1.31
    Next Earnings Date:27-Feb-15ISIS Earnings announcement
    Day's Range:66.50 - 68.38
    52wk Range:22.25 - 75.24
    Volume:2,609,430
    Avg Vol (3m):3,318,470
    Market Cap:7.95B
    P/E (ttm):N/A
    EPS (ttm):-0.81
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ISIS

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):46.93
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.59
    Quarterly EPS Est (Dec-14) :0.02
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):-4.93

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Isis Pharmaceuticals, Inc. is engaged in the discovery and development of antisense drugs using novel drug discovery platform. The company’s flagship product includes the KYNAMRO injection, which is an apo-B synthesis inhibitor for patients w... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback